Suppression of Class I and II Histone Deacetylases Blunts Pressure-Overload Cardiac Hypertrophy
Circulation2006Vol. 113(22), pp. 2579–2588
Citations Over TimeTop 10% of 2006 papers
Yongli Kong, Paul Tannous, Guangrong Lu, Kambeez Berenji, Beverly A. Rothermel, Eric N. Olson, Joseph A. Hill
Abstract
Together, these data suggest that HDAC inhibition is a viable therapeutic strategy that holds promise in the treatment of load-induced heart disease.
Related Papers
- → Extracellular signal-regulated kinase (ERK) activation preserves cardiac function in pressure overload induced hypertrophy(2018)44 cited
- [Is secondary myocardial hypertrophy a physiological or pathological adaptive mechanism?].(1982)
- [Apoptosis in pressure overload-induced heart hypertrophy].(2001)
- Abstract 14858: CRD-733, a Novel Phosphodiesterase 9 Inhibitor, Reverses Pressure Overload-Induced Cardiac Hypertrophy in Mice(2018)